192 related articles for article (PubMed ID: 1635555)
1. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
Cheon HG; Boteju LW; Hanna PE
Mol Pharmacol; 1992 Jul; 42(1):82-93. PubMed ID: 1635555
[TBL] [Abstract][Full Text] [Related]
2. Chemical modification of hamster arylamine N-acetyltransferase 2 with isozyme-selective and nonselective N-arylbromoacetamido reagents.
Wang H; Guo Z; Vath GM; Wagner CR; Hanna PE
Protein J; 2004 Feb; 23(2):153-66. PubMed ID: 15106881
[TBL] [Abstract][Full Text] [Related]
3. Effect of group-selective modification reagents on arylamine N-acetyltransferase activities.
Cheon HG; Hanna PE
Biochem Pharmacol; 1992 May; 43(10):2255-68. PubMed ID: 1599511
[TBL] [Abstract][Full Text] [Related]
4. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
5. Arylamine N-acetyltransferases: covalent modification and inactivation of hamster NAT1 by bromoacetamido derivatives of aniline and 2-aminofluorene.
Guo Z; Vath GM; Wagner CR; Hanna PE
J Protein Chem; 2003 Nov; 22(7-8):631-42. PubMed ID: 14714730
[TBL] [Abstract][Full Text] [Related]
6. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
[TBL] [Abstract][Full Text] [Related]
7. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene.
Guo Z; Wagner CR; Hanna PE
Chem Res Toxicol; 2004 Mar; 17(3):275-86. PubMed ID: 15025497
[TBL] [Abstract][Full Text] [Related]
9. Bioactivation of N-arylhydroxamic acids by rat hepatic N-acetyltransferase. Detection of multiple enzyme forms by mechanism-based inactivation.
Wick MJ; Hanna PE
Biochem Pharmacol; 1990 Mar; 39(6):991-1003. PubMed ID: 2322300
[TBL] [Abstract][Full Text] [Related]
10. Irreversible inactivation of arylamine N-acetyltransferases in the presence of N-hydroxy-4-acetylaminobiphenyl: a comparison of human and hamster enzymes.
Wang H; Wagner CR; Hanna PE
Chem Res Toxicol; 2005 Feb; 18(2):183-97. PubMed ID: 15720122
[TBL] [Abstract][Full Text] [Related]
11. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase.
Mattano SS; Land S; King CM; Weber WW
Mol Pharmacol; 1989 May; 35(5):599-609. PubMed ID: 2725469
[TBL] [Abstract][Full Text] [Related]
12. Hepatic N-acetyltransferases: selective inactivation in vivo by a carcinogenic N-arylhydroxamic acid.
Smith TJ; Hanna PE
Biochem Pharmacol; 1988 Feb; 37(3):427-34. PubMed ID: 3257389
[TBL] [Abstract][Full Text] [Related]
13. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes.
Smith TJ; Hanna PE
Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051
[TBL] [Abstract][Full Text] [Related]
14. Characterization of hamster recombinant monomorphic and polymorphic arylamine N-acetyltransferases: bioactivation and mechanism-based inactivation studies with N-hydroxy-2-acetylaminofluorene.
Sticha KR; Bergstrom CP; Wagner CR; Hanna PE
Biochem Pharmacol; 1998 Jul; 56(1):47-59. PubMed ID: 9698088
[TBL] [Abstract][Full Text] [Related]
15. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
Wagner CR; Bergstrom CP; Koning KR; Hanna PE
Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
[TBL] [Abstract][Full Text] [Related]
16. Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
Hanna PE; Banks RB; Marhevka VC
Mol Pharmacol; 1982 Jan; 21(1):159-65. PubMed ID: 7132954
[TBL] [Abstract][Full Text] [Related]
17. An isozyme-selective affinity label for rat hepatic acetyltransferases.
Wick MJ; Yeh HM; Hanna PE
Biochem Pharmacol; 1990 Sep; 40(6):1389-98. PubMed ID: 2403393
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of hamster monomorphic N-acetyltransferase by vinyl fluorenyl ketone.
Wick MJ; Hanna PE
Biochem Pharmacol; 1994 Nov; 48(9):1835-8. PubMed ID: 7980653
[TBL] [Abstract][Full Text] [Related]
19. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol.
Yerokun T; Kirlin WG; Trinidad A; Ferguson RJ; Ogolla F; Andrews AF; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):231-7. PubMed ID: 2568902
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and large-scale purification of recombinant hamster polymorphic arylamine N-acetyltransferase as a dihydrofolate reductase fusion protein.
Sticha KR; Sieg CA; Bergstrom CP; Hanna PE; Wagner CR
Protein Expr Purif; 1997 Jun; 10(1):141-53. PubMed ID: 9179301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
